These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 32240804)

  • 41. Adsorption rate constants of therapeutic proteins and surfactants for material surfaces.
    Lefebvre G; Bruckert F; Filipe V; Huille S; Weidenhaupt M
    Colloids Surf B Biointerfaces; 2021 Jul; 203():111722. PubMed ID: 33839475
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Edetate Disodium as a Polysorbate Degradation and Monoclonal Antibody Oxidation Stabilizer.
    Yarbrough M; Hodge T; Menard D; Jerome R; Ryczek J; Moore D; Baldus P; Warne N; Ohtake S
    J Pharm Sci; 2019 Apr; 108(4):1631-1635. PubMed ID: 30502482
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Design of Biopharmaceutical Formulations Accelerated by Machine Learning.
    Narayanan H; Dingfelder F; Condado Morales I; Patel B; Heding KE; Bjelke JR; Egebjerg T; Butté A; Sokolov M; Lorenzen N; Arosio P
    Mol Pharm; 2021 Oct; 18(10):3843-3853. PubMed ID: 34519511
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Free fatty acid particles in protein formulations, part 2: contribution of polysorbate raw material.
    Siska CC; Pierini CJ; Lau HR; Latypov RF; Fesinmeyer RM; Litowski JR
    J Pharm Sci; 2015 Feb; 104(2):447-56. PubMed ID: 25196966
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hydrolytic polysorbate 20 degradation - Sensitive detection of free fatty acids in biopharmaceuticals via UPLC-QDa analytics with isolator column.
    Evers DH; Carle S; Lakatos D; Hämmerling F; Garidel P; Buske J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jun; 1174():122717. PubMed ID: 33975273
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rational design of a stable, freeze-dried virus-like particle-based vaccine formulation.
    Lang R; Winter G; Vogt L; Zurcher A; Dorigo B; Schimmele B
    Drug Dev Ind Pharm; 2009 Jan; 35(1):83-97. PubMed ID: 19016059
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Aggregation and Particle Formation of Therapeutic Proteins in Contact With a Novel Fluoropolymer Surface Versus Siliconized Surfaces: Effects of Agitation in Vials and in Prefilled Syringes.
    Teska BM; Brake JM; Tronto GS; Carpenter JF
    J Pharm Sci; 2016 Jul; 105(7):2053-65. PubMed ID: 27233685
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Spray drying of pharmaceuticals and biopharmaceuticals: Critical parameters and experimental process optimization approaches.
    Ziaee A; Albadarin AB; Padrela L; Femmer T; O'Reilly E; Walker G
    Eur J Pharm Sci; 2019 Jan; 127():300-318. PubMed ID: 30428336
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Accelerate development of topical cream drug product using a common platform base formulation.
    Modi D; Sharma H; Campbell G
    Pharm Dev Technol; 2020 Jul; 25(6):767-778. PubMed ID: 32176856
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Industry Perspective on the use and Characterization of Polysorbates for Biopharmaceutical Products Part 1: Survey Report on Current State and Common Practices for Handling and Control of Polysorbates.
    Wuchner K; Yi L; Chery C; Nikels F; Junge F; Crotts G; Rinaldi G; Starkey JA; Bechtold-Peters K; Shuman M; Leiss M; Jahn M; Garidel P; de Ruiter R; Richer SM; Cao S; Peuker S; Huille S; Wang T; Le Brun V
    J Pharm Sci; 2022 May; 111(5):1280-1291. PubMed ID: 35192858
    [TBL] [Abstract][Full Text] [Related]  

  • 51. On-line coupling of hydrophobic interaction column with reverse phase column -charged aerosol detector/mass spectrometer to characterize polysorbates in therapeutic protein formulations.
    He Y; Brown P; Bailey Piatchek MR; Carroll JA; Jones MT
    J Chromatogr A; 2019 Feb; 1586():72-81. PubMed ID: 30551943
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Protein-Excipient Interactions Evaluated via Nuclear Magnetic Resonance Studies in Polysorbate-Based Multidose Protein Formulations: Influence on Antimicrobial Efficacy and Potential Study Approach.
    Torosantucci R; Furtmann B; Elshorst B; Pfeiffer-Marek S; Hartleb T; Andres N; Bussemer T
    J Pharm Sci; 2018 Oct; 107(10):2531-2537. PubMed ID: 29883667
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Understanding Particle Formation: Solubility of Free Fatty Acids as Polysorbate 20 Degradation Byproducts in Therapeutic Monoclonal Antibody Formulations.
    Doshi N; Demeule B; Yadav S
    Mol Pharm; 2015 Nov; 12(11):3792-804. PubMed ID: 26419285
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development of a lyophilization formulation that preserves the biological activity of the platelet-inducing cytokine interleukin-11 at low concentrations.
    Page C; Dawson P; Woollacott D; Thorpe R; Mire-Sluis A
    J Pharm Pharmacol; 2000 Jan; 52(1):19-26. PubMed ID: 10716599
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pediatric Safety of Polysorbates in Drug Formulations.
    Kriegel C; Festag M; Kishore RSK; Roethlisberger D; Schmitt G
    Children (Basel); 2019 Dec; 7(1):. PubMed ID: 31877624
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Monitoring polysorbate hydrolysis in biopharmaceuticals using a QC-ready free fatty acid quantification method.
    Honemann MN; Wendler J; Graf T; Bathke A; Bell CH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 May; 1116():1-8. PubMed ID: 30951966
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Product-Specific Impact of Viscosity Modulating Formulation Excipients During Ultra-High Concentration Biotherapeutics Drug Product Development.
    Rodrigues D; Tanenbaum LM; Thirumangalathu R; Somani S; Zhang K; Kumar V; Amin K; Thakkar SV
    J Pharm Sci; 2021 Mar; 110(3):1077-1082. PubMed ID: 33340533
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reduced Subvisible Particle Formation in Lyophilized Intravenous Immunoglobulin Formulations Containing Polysorbate 20.
    Zhou C; Qi W; Lewis EN; Randolph TW; Carpenter JF
    J Pharm Sci; 2016 Aug; 105(8):2302-9. PubMed ID: 27290624
    [TBL] [Abstract][Full Text] [Related]  

  • 59. IgG1 adsorption to siliconized glass vials-influence of pH, ionic strength, and nonionic surfactants.
    Höger K; Mathes J; Frieß W
    J Pharm Sci; 2015 Jan; 104(1):34-43. PubMed ID: 25394280
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An Industry Perspective on Forced Degradation Studies of Biopharmaceuticals: Survey Outcome and Recommendations.
    Halley J; Chou YR; Cicchino C; Huang M; Sharma V; Tan NC; Thakkar S; Zhou LL; Al-Azzam W; Cornen S; Gauden M; Gu Z; Kar S; Lazar AC; Mehndiratta P; Smith J; Sosic Z; Weisbach P; Stokes ESE
    J Pharm Sci; 2020 Jan; 109(1):6-21. PubMed ID: 31563512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.